
Theranica Secures $45 Million Series C Funding Round
Theranica advises the proceeds will fund the U.S. commercial expansion of migraine treatment device , Nerivio®
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor

Theranica Secures $45 Million Series C Funding Round
Theranica advises the proceeds will fund the U.S. commercial expansion of migraine treatment device , Nerivio®